DNP DNP SELECT INCOME FUND INC Insider Trading

Director Kahrer buys 20,000 DNP shares for $204,200 at $10.21, raising stake 666.7% to 23,000 shares

Mark G. Kahrer, a director, purchased 20,000 shares at $10.21 on 2026-02-11, increasing his holdings from 3,000 to 23,000 shares—a 666.7% increase. At the time of purchase, the stock was trading within its 52-week range at $10.21, only 0.6% below its 52-week high of $10.33. While the director's cross-ticker track record shows 2 prior buys with a 50.00% 90-day win rate and average 90-day return of +1.3%, this material accumulation represents a significant shift in personal positioning at this specific ticker with no prior measurable same-ticker transaction history to establish a pattern.

DNP President & CEO Grumhaus bought 2,000 shares at $9.60; holdings now 8,361 shares, mirroring successful prior purchase pattern at this ticker.

Grumhaus David D Jr. purchased 2,000 shares of DNP SELECT INCOME FUND INC at $9.60 on 2024-11-26, increasing his holdings by 31.4% to 8,361 shares. His sole prior open-market transaction at DNP—a purchase on 2023-12-12—generated a 90-day return of +9.5%, demonstrating well-timed accumulation at this specific ticker. The current transaction follows a similar pattern: open-market discretionary purchase at the same issuer where he has shown prior success in entry timing. The cross-ticker track record shows 80.00% 90-day win rate across 6 prior buys with avg 90d return +0.1%, providing context that his timing at DNP specifically has outperformed his broader pattern. The stock is currently trading at $9.65, down -3.9% from its 52-week high of $10.04, placing the recent purchase near the lower range of the 52-week band.

MetLife Investment Management (10% owner) purchases 3,100,000 shares of DNP at $3,100,000.00 on 2024-07-22; position value $9,610,000,000,000.00.

MetLife Investment Management, already a 10% owner, executed a substantial acquisition of 3,100,000 shares valued at $9,610,000,000,000.00 on 2024-07-22. The current price of $8.71 is -15.3% from the 52-week high of $10.28, placing the purchase in a drawdown period; however, the stock has recovered +5.6% over the prior 30 days. This scale of accumulation by a major institutional stakeholder warrants examination of whether it reflects portfolio rebalancing by an asset manager or a signal regarding the fund's positioning. The transaction's magnitude and the purchaser's already-significant ownership stake make this material for investors monitoring DNP's shareholder composition and institutional conviction.

Director McLoughlin buys 2,500 shares of DNP at $8.33; stock down 19.9% from 52-week high.

Philip R McLoughlin, a director, purchased 2,500 shares at $8.33 on July 8, 2024, increasing his stake to 18,317 shares from 15,817 shares. The purchase occurred while DNP trades at $8.31, approximately -19.9% below its 52-week high of $10.38 and down 7.5% over the past 90 days. This buy represents a 15.8% increase in his holdings and occurs in a context of sustained price weakness, making the timing relevant to understanding insider appetite at current valuation levels.

EVP Petrisko buys 800 DNP shares at $8.13; holdings rise to 3,569 (+28.9%)

Daniel Petrisko, Executive Vice President, purchased 800 shares of DNP SELECT INCOME FUND INC at $8.13 on 2024-06-20, increasing his holdings by 28.9% from 2,769 to 3,569 shares for a total of $6,500.24. His prior buy at this ticker on 2023-12-20 delivered a 90-day return of +7.0%, establishing a track record of well-timed accumulation at DNP. However, the current price of $8.15 is down 22.2% from the 52-week high of $10.48 and down 7.0% over the past 30 days, reflecting broader weakness in the fund's performance. The timing and size of this purchase warrant monitoring to determine whether it represents renewed conviction or a routine rebalancing activity in a dividend-focused closed-end fund.

West Kyle P. buys 1,000 DNP shares at $8.24; stock down 22.2% from 52-week high.

West Kyle P. purchased 1,000 shares at $8.24 on 2024-06-14, bringing his holdings to 7,176 shares—a 16.2% increase from prior holdings. The purchase occurs while the stock trades at $8.15 current price, down 22.2% from its 52-week high of $10.48 and down 8.0% over the past 30 days. His same-ticker history at DNP shows mixed outcomes: a December 2023 buy generated a 90-day return of +4.9%, while an October 2023 buy returned -8.3% over 90 days, with only 1 of 2 prior trades well-timed at the 90-day mark. His broader cross-ticker track record shows 2 prior buys with an average 30-day return of +2.5% but an average 90-day return of -1.7% and a 50.00% win rate, indicating inconsistent execution across holdings.